Cargando…

Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease: associated beta amyloid protein

Natural products have played a dominant role in the discovery of lead compounds for the development of drugs aimed at the treatment of human diseases. This electrospray ionization-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS)—based study demonstrates that dietary antioxidants, isolated co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koulakiotis, Nikolaos Stavros, Purhonen, Pasi, Gikas, Evangelos, Hebert, Hans, Tsarbopoulos, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585429/ https://www.ncbi.nlm.nih.gov/pubmed/33097779 http://dx.doi.org/10.1038/s41598-020-74770-x

Ejemplares similares

Publisher Correction: Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease - associated beta amyloid protein
por: Koulakiotis, Nikolaos Stavros, et al.
Publicado: (2021)

Phytochemical Differentiation of Saffron (Crocus sativus L.) by High Resolution Mass Spectrometry Metabolomic Studies
por: Gikas, Evangelos, et al.
Publicado: (2021)

The Crocus sativus Compounds trans-Crocin 4 and trans-Crocetin Modulate the Amyloidogenic Pathway and Tau Misprocessing in Alzheimer Disease Neuronal Cell Culture Models
por: Chalatsa, Ioanna, et al.
Publicado: (2019)

Familial Alzheimer’s Disease-Related Mutations Differentially Alter Stability of Amyloid-Beta Aggregates
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2023)

Structure of potassium channels
por: Kuang, Qie, et al.
Publicado: (2015)

Two-Dimensional Crystallization Procedure, from Protein Expression to Sample Preparation
por: Kuang, Qie, et al.
Publicado: (2015)

A Novel Validated Injectable Colistimethate Sodium Analysis Combining Advanced Chemometrics and Design of Experiments
por: Dagla, Ioanna, et al.
Publicado: (2021)

Colistimethate Acidic Hydrolysis Revisited: Arrhenius Equation Modeling Using UPLC-QToF MS
por: Dagla, Ioanna, et al.
Publicado: (2021)

Two Fast GC-MS Methods for the Measurement of Nicotine, Propylene Glycol, Vegetable Glycol, Ethylmaltol, Diacetyl, and Acetylpropionyl in Refill Liquids for E-Cigarettes
por: Dagla, Ioanna, et al.
Publicado: (2023)

Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
por: Esparza, Thomas J., et al.
Publicado: (2016)

Arachidonic acid promotes the binding of 5-lipoxygenase on nanodiscs containing 5-lipoxygenase activating protein in the absence of calcium-ions
por: Kumar, Ramakrishnan B., et al.
Publicado: (2020)

Targeted Metabolomics: The LC-MS/MS Based Quantification of the Metabolites Involved in the Methylation Biochemical Pathways
por: Ntasi, Georgia, et al.
Publicado: (2021)

Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015)

Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
por: Phan, Huong T. T., et al.
Publicado: (2019)

Amyloid-beta aggregation implicates multiple pathways in Alzheimer’s disease: Understanding the mechanisms
por: Iliyasu, Musa O., et al.
Publicado: (2023)

Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response
por: Dagla, Ioanna, et al.
Publicado: (2022)

Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
por: Sharari, Sanaa, et al.
Publicado: (2023)

Effect of Supplementation with Olive Leaf Extract Enriched with Oleuropein on the Metabolome and Redox Status of Athletes’ Blood and Urine—A Metabolomic Approach
por: Lemonakis, Nikolaos, et al.
Publicado: (2022)

Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer’s disease
por: Boubakri, Abdelbasset, et al.
Publicado: (2020)

Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease
por: Sideris, Dimitrios I, et al.
Publicado: (2021)

Effect of Bacterial Amyloid Protein Phenol−Soluble Modulin Alpha 3 on the Aggregation of Amyloid Beta Protein Associated with Alzheimer’s Disease
por: Peng, Bushu, et al.
Publicado: (2023)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
por: Köppen, Janett, et al.
Publicado: (2020)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer’s disease pathogenesis
por: Li, Nuo-Min, et al.
Publicado: (2019)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
por: Du, Hongtao, et al.
Publicado: (2023)

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
por: Sepkhanova, I., et al.
Publicado: (2009)

Magnetoelectric dissociation of Alzheimer’s β-amyloid aggregates
por: Jang, Jinhyeong, et al.
Publicado: (2022)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Amyloid Beta Aggregation in the Presence of Temperature-Sensitive Polymers
por: Funtan, Sebastian, et al.
Publicado: (2016)

Oxidation destabilizes toxic amyloid beta peptide aggregation
por: Razzokov, J., et al.
Publicado: (2019)

Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity
por: Khavandi, Marzie, et al.
Publicado: (2023)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
por: Wagner, Jessica, et al.
Publicado: (2022)

Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression
por: Findley, Caleigh A., et al.
Publicado: (2019)

Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
por: Proctor, Carole J, et al.
Publicado: (2012)

A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
por: Rofo, Fadi, et al.
Publicado: (2022)

In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
por: Job, Nisha, et al.
Publicado: (2023)

Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
por: Shao, Xu, et al.
Publicado: (2022)

Halogenation Generates Effective Modulators of Amyloid-Beta Aggregation and Neurotoxicity
por: Wong, H. Edward, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jb8j7n72ckeega82pmhlg385sp